**Core tip:** Esophageal insufflation computed tomography (EICT) is a method of insufflating air into the stomach before computed tomography examination, which fully expands the esophageal lumen. The optimal monochromatic energy level clearly displays esophageal lesions and surrounding adipose infiltration by means of effectively improving the image quality and resolution. Our study demonstrates that EICT combined with GSI assist technology contributes to better performance in the differential diagnosis between the T1/2 *vs* T3 stages and the T3 *vs* T4 stages in medullary esophageal cancer.

INTRODUCTION
============

Esophageal carcinoma (EC) is a common malignant tumor of the digestive system. Mortality due to EC is approximately 300000 people per year worldwide\[[@B1]\]. The most common pathology subtype in Asia is esophageal squamous cell carcinoma (ESCC). As it is rare for patients to exhibit early symptoms of ESCC, patients typically receive treatment in the mid- and late stages (T3/4, N+ or M1)\[[@B2]\]. The overall five-year survival rate of progressive ESCC (T3/4 or N+) is only 42% after surgical resection or preoperative neoadjuvant chemotherapy\[[@B3]\]. Identification of the correct T stage of ESCC by preoperative imaging plays a critical role in the development, treatment and prognosis of patients.

Endoscopic ultrasonography (EUS) can be used clinically to determine the infiltration of ESCC and the possibility of surgical resection. However, the detection range is limited to centimeters from the center of the ultrasonic probe without interference or severe stenosis. Griffin et al\[[@B4]\] reported that inflammation or fibrous tissue surrounding ESCC tissue leads to over-staging of the local T stage. Currently, computed tomography (CT) and positron emission tomography/computed tomography (PET/CT) are common methods used to evaluate the T stage before ESCC treatment\[[@B5]-[@B7]\]. Variations in the sensitivity and specificity of these common methods is 27%-67% and 33%-93%, respectively\[[@B8],[@B9]\]. Some studies continue to use traditional CT enhancement with low spatial and density resolutions. Konieczny et al\[[@B10]\] asserted that the accuracy of traditional 64-slice CT enhancement was 34% for EC. The sensitivity and specificity of CT or PET/CT are approximately 31% and 59% for diagnosis of the T1/2 stage, 60% and 64% for diagnosis of the T3 stage, and 100% and 4% for diagnosis of the T4 stage, respectively, which are not satisfactory.

Conventional CT has limitations for ESCC staging or restaging after treatment. Esophageal insufflation CT (EICT) is a method of insufflating air into the stomach before CT examination, which fully expands the esophageal lumen\[[@B11]\]. Diagnosis of the T1 or T2 stage has low accuracy because of the difficulty in visualizing the esophageal mucosa\[[@B12],[@B13]\]. The optimal monochromatic energy level clearly displays esophageal lesions and the surrounding adipose infiltration by effectively improving the image quality and resolution. The optimal monochromatic energy level can be used for diagnosis, treatment selection, and therapeutic monitoring. Hence, we aimed to evaluate the T stage of ESCC using low-dose spectral insufflation CT, and we discuss the accuracy of this technique for diagnosing the T stage preoperatively.

MATERIALS AND METHODS
=====================

Subject enrollment
------------------

This study was approved by the Institutional Review Board. All patients enrolled in this study provided informed consent.

In this single-institution study, 120 patients with a biopsy-proven esophageal malignancy who were being considered for radical treatment and who had already undergone EUS with a median age of 58 years (range, 48-83 years) were recruited from November 2015 to August 2017. The patients included 66 males and 54 females, with a median age of 55.4 years (range, 48-83 years). The typical clinical symptoms included vomiting, progressive dysphagia, intermittent sternal sensation, hematemesis and a sense of frustration. All patients considered for radical treatment were staged according to spectral CT and EUS within 6 wk.

The exclusion criteria included the following: (1) patients with esophageal cancer undergoing spectral CT to detect recurrence; (2) patients with a poor physical condition or a combination of severe heart, liver or kidney dysfunction; (3) patients with a history of iodine allergy, making them unsuitable for enhanced examination; and (4) patients with a history of other cancers.

Spectral CT protocol and data acquisition
-----------------------------------------

Patients were divided into three groups that included 45 patients (group A), 40 patients (group B) and 35 patients (group C). Patients were required to fast for 6 h prior to the investigation and were administered an intramuscular injection of amidoamine (20 mg) 10-15 min before experimental procedures. EUS was performed using a PHILIP IU22 Color Doppler Diagnostic Apparatus (Philip, Eindhoven, The Netherlands) with a 5-10 Hz radical or linear endoscope. Then, a dual-phase contrast enhancement spectral spiral CT was performed with a spectral CT scanner (Discovery CT, GE Healthcare, Waukesha, WI, United States) from the thoracic inlet to the bottom of the lungs. The imaging parameters for group B were as follows: tube voltage: 80 kV and 140 kV with a fast kV-switching technique; tube current: auto mA with a slice thickness of 5 mm. Iobitrido (Guerbet, Paris, French), containing 350 mg/mL of iodine, was injected at a dose of 300 mgI/kg. The injection rate was calculated as the weight in kilograms divided by 30 s. A triggering scan was performed when the CT attenuation of the aortic arch reached the level of 100 HU. The starting time was 90 s after triggering. The saline tracer injection rate was similar to that of the contrast medium. For group A, conventional 120 kVp chest-enhanced CT scanning was performed with an injection dose of 450 mgI/kg. The remaining parameters were similar to those of group B.

For group C, a gastric tube was inserted into the stomach *via* the nasal cavity 10-15 min before the CT examination. The depth of insertion was referenced to the location of the esophageal lesion, and the end of the tube was fixed near the nostrils. Patients were asked to press a balloon to fill the stomach with air. Pressure was maintained between 4-4.67 kPa. Patients were required to keep their lips tightly closed and to fill the esophagus as much as possible during the process of filling. The rest of the parameters were similar to those of group B.

Qualitative and quantitative analyses
-------------------------------------

CT images (40-140 keV, monochromatic) were reconstructed using spectral imaging analysis software (GE Healthcare, Waukesha, WI, United States). The 50% adaptive statistical iterative reconstruction (ASIR) algorithm and standard filtered back projection reconstruction were applied to the decomposition images of group A and groups B and C, respectively. A flowchart of the study procedures is shown in Figure [1](#F1){ref-type="fig"}.

![Study flow chart. ESCC: Esophageal squamous cell carcinoma; FBP: Filtered back projection; EICT: Esophageal insufflation computed tomography; ASIR: Adaptive statistical iterative reconstruction.](WJG-24-4197-g001){#F1}

Special CT features observation
-------------------------------

Two radiologists (Zha KJ and Zhou Y) with ten years of experience in CT diagnosis independently observed and recorded the special features of the CT images in a blinded and randomized manner using a dedicated workstation (Advantage Workstation 4.6, GE Healthcare, Waukesha, WI, United States). In the case of a discrepancy between interpretations, a consensus was reached by discussion. The main observations included enhanced features for ESCC (layered/unlayered enhancement) and morphological changes near ESCC tissue (a triangle area in front of the vertebral body, trachea, bronchus and aorta). A layered enhanced feature for ESCC was used to clearly identify the layers of the esophageal wall to effectively determine infiltration.

As described in Figure [2A](#F2){ref-type="fig"}, the triangular area in front of the vertebral body is surrounded by the outer esophageal membrane, the thoracic aorta and the vertebral body. Under normal circumstances, this area is filled with adipose tissue; however, when invaded by ESCC, this area is blurred or disappears. The narrow space between the anterior wall of the esophagus and the trachea is connected by loose connective tissue. When the tracheal bronchus is invaded, the space is depicted as having an ill-defined boundary or tracheal bronchus deformation and displacement. In general, the contact arc between the tumor and the thoracic aorta is less than 45°, while an arc of 45°-90° indicates invasion, and an arc larger than 90° indicates thoracic aorta invasion (Figure [2B](#F2){ref-type="fig"}).

![The morphological features of the triangular area in front of the vertebral body. A: Sketch of the triangular area. The triangular space is surrounded by the outer esophageal membrane, thoracic aorta and vertebral body. B: The contact arc between the tumor and thoracic aorta is less than 45°; a contact arc of 45-90° corresponds to suspected invasion, and a contact arc larger than 90° indicates thoracic aorta invasion. VB: Vertebral body.](WJG-24-4197-g002){#F2}

Subjective imaging evaluation
-----------------------------

From the monochromatic images, an analysis was performed to obtain the optimal energy level to provide the best contrast-to-noise ratio (CNR) between ESCC tissue and surrounding adipose tissue. Selected circular or oval-shaped areas from 70-80 mm^2^ were used for the regions of interest (ROI) measurement, which contained ESCC tissue and surrounding adipose tissue. The GSI Viewer software package automatically calculated the best CNR values from 101 sets of monochromatic images. The standard deviation (SD) of adipose tissue inside the mediastinal space at the same level represents image noise. The ROI was placed in the region as homogeneously as possible (an average of three ROIs). CNR was calculated using the following formula: CNR=(CT~ESCC~-CT~adipose~)/SD~adipose~. The normalized iodine concentration was obtained by dividing the iodine concentration (IC) for ESCC tissue (IC~ESCC~) by that for the aorta (IC~aorta~). The normalized iodine concentration (NIC) was calculated as NIC = IC~ESCC~/IC~aorta~.

Radiation dose
--------------

The volume CT dose index (CTDIvol, mGy) and dose-length product (DLP, mGy•cm) in the dose report were also recorded. The estimated effective dose (ED, mSv) was calculated by multiplying the DLP by 0.014 (as recommended by the International Commission on Radiological Protection (ICRP) for chest CT examinations).

Pathological subtype and T stage
--------------------------------

The spectral CT results were compared with the results of other combined staging investigations, such as EUS and PET. For unresectable disease, sections were obtained for histological assessment, additional imaging \[PET/CT, magnetic resonance imaging (MRI)\] or clinical course determination, such as rapidly progressive disease or response to treatment. For potentially resectable disease, lesion sections were taken and frozen at the time of resection when appropriate, and information was obtained upon subsequent relapse and survival.

The T stage was reported according to the maximum wall thickness of ESCC tissue using the criteria of the classification system by Konieczny et al\[[@B10]\] and Jones et al\[[@B14]\], and consistent with the 7^th^ TNM edition\[[@B4],[@B15]\]. The T status for CT diagnosis was defined as follows: the T1 and T2 stages were combined because it was impossible to differentiate between the esophageal wall layers on MDCT images. The T1/2 stage was defined as a tumor wall thickness of at least 5-10 mm without evidence of mediastinal involvement. The T3 stage was defined as a tumor wall thickness greater than 10 mm with mediastinal involvement but no invasion of adjacent structures. The T4a (invasion of pleura, pericardium and diaphragm) and T4b (invasion of other structures, *e.g*., aorta, vertebral body and trachea) stages were defined as a tumor wall thickness greater than 10 mm and invaded adjacent structures.

The pathological subtype was classified based on the advanced esophagus cancer pathology classification criteria of the NCCN guidelines (2017. V3). The pathological subtypes included medullary type (wall thickness with symmetry or partial lumen stenosis), mushroom type (wall thickness similar to a flat mushroom mass), ulcer type (a larger and deeper ulcer on the surface of the wall) and narrowing type (narrow and obstructed lumen with a dilated upper segment).

Statistical analysis
--------------------

The Statistical Package for the Social Sciences version 19.0 software program (SPSS, Inc., Chicago, IL, United States) was used for statistical analyses. Quantitative variables are expressed as the mean ± SD. Paired *t*-tests were used to compare age, BMI and radiation dose among the image reconstruction protocols. One-way analysis of variance was used to compare objective image noise. The least significant difference correction was used for multiple comparisons. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy for determining the T stage of the three groups were calculated, and the positive predictive value and negative predictive value were calculated. Inter-observer agreements between the two radiologists were based on the percentage agreement and simple Cohen's kappa statistic. The significance level for all tests was 5% (two-sided).

RESULTS
=======

The basic characteristics of the patients are summarized in Table [1](#T1){ref-type="table"}. No significant differences were found in gender, tumor location, differentiation, and clinical symptoms among groups (*P* \< 0.05 for all). The medullary type comprised the largest proportion in each group, followed by the mushroom and ulcer types; the narrowing type corresponded to the smallest proportion.

###### 

Basic clinical characteristics of patients *n* (%)

  **Variable**                           **Group A (*n* = 45)**   **Group B (*n* = 40)**   **Group C (*n* = 35)**
  -------------------------------------- ------------------------ ------------------------ ------------------------
  Gender                                                                                   
  Male                                   25 (56)                  19 (48)                  22 (64)
  Female                                 50 (44)                  21 (52)                  13 (36)
  Age (yr)                                                                                 
  Medium                                 67                       61                       63
  Range                                  55-82                    52-79                    50-81
  Location                                                                                 
  Upper esophagus                        11 (24)                  8 (20)                   6 (16)
  Middle esophagus                       14 (32)                  11 (28)                  11 (32)
  Lower esophagus                        20 (44)                  22 (56)                  18 (52)
  Differentiation degree                                                                   
  High                                   17 (38)                  9 (23)                   10 (28)
  Medium                                 23 (50)                  25 (62)                  14 (40)
  Low                                    5 (12)                   6 (15)                   11 (32)
  Symptom                                                                                  
  Progressive dysphagia                  18 (40)                  19 (48)                  21 (60)
  Vomiting                               13 (28)                  8 (20)                   4 (12)
  Intermittent sternal sensation         9 (20)                   8 (20)                   6 (16)
  Hematemesis and sense of frustration   5 (12)                   5 (12)                   4 (12)

Special CT features for T1/2 and T3 stage differentiation
---------------------------------------------------------

The proportions of layered enhancement in medullary ESCC tissue in groups A, B and C were 33%, 56% and 75% (for the T1/2 stage) and 20%, 20% and 11% (for the T3 stage), respectively; those for ulcer type were 33%, 0% and 33% (for the T1/2 stage) and 0%, 0% and 20% (for the T3 stage); and those for mushroom type were 20%, 0% and 60% (for the T1/2 stage) and 0% for all groups (for the T3 stage). The presentation of layered enhancement significantly differed between T1/2 and T3 stage medullary ESCC in group C (*P* \< 0.05) but not between those stages in groups A and B (*P* \> 0.05), and there was no significant difference between the T1/2 and T3 stages in the ulcer and mushroom types (*P* \> 0.05 for all) (Table [2](#T2){ref-type="table"}, Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}).

###### 

Comparison between esophageal squamous cell carcinoma-enhanced features and pathological T stage

  **Group**   **Enhancement feature**   **Medullary type**   **Ulcerative type**   **Mushroom type**   **Total**            
  ----------- ------------------------- -------------------- --------------------- ------------------- ----------- --- ---- ----
  A           Layered                   3                    2                     2                   0           1   0    8
  Unlayered   6                         8                    6                     4                   4           3   31   
  Total       9                         10                   8                     4                   5           3   39   
  B           Layered                   5                    2                     0                   0           0   0    7
  Unlayered   4                         8                    2                     5                   4           3   26   
  Total       9                         10                   2                     5                   4           3   33   
  C           Layered                   6                    1                     1                   1           3   0    12
  Unlayered   2                         8                    2                     4                   2           2   20   
  Total       8                         9                    3                     5                   5           2   22   

![Typical cases showing the esophageal wall of group A, B and C. A: A sagittal reformatted image obtained *via* 120 kVp combined with FBP reconstruction shows unlayered enhanced esophageal cancer in a 53-year old patient (yellow arrow). The esophageal wall appears to be generally thickened over a long distance but without an enhanced layer. B: Moderately enhanced esophageal cancer in the lower esophagus of a 61-year old patient. The coronal reformatted image obtained *via* EICT combined with GSI assist at 50 KeV shows that the lesion appears to protrude into the lumen (yellow arrow). The lumen is filled with air without esophageal wall shrinkage. C: A 63-year old patient with histopathological T2N0M0. The axial image in the venous phase shows esophageal wall thickening, but it is difficult to identify layers (yellow arrow). Due to nose or mouth leakage, non-EICT is displayed in the venous phase for this patient. D-F: The same patient as in (C); axial and sagittal images obtained *via* EICT combined with GSI assist at 50 KeV show the wall thickness as if a partial mass was present with a moderate enhancement in the arterial phase (yellow arrow). EICT: Esophageal insufflation computed tomography.](WJG-24-4197-g003){#F3}

![Typical cases between T1/2 and T3 stages of esophageal squamous cell carcinoma in group A, B and C. A: An axial image obtained *via* 120 kVp combined with FBP reconstruction of a 56-year old patient shows unlayered enhanced wall thickening at the lower esophagus with histopathological T2N0M0. B: A 62-year old, correctly-staged patient with histopathological T2N0M0ESCC of the middle esophagus. The axial image at 50 KeV obtained by GSI assist depicts significantly layered enhanced wall thickening, which was regarded as invasion within the submucosal or muscle layer. C: A 58-year old patient with histopathological T2N0M0; sagittal reformatted image obtained *via* EICT combined with GSI assist at 50 KeV shows slightly mucosal enhanced wall thickening with an ulcer on the surface. D: An axial image obtained *via* 120 kVp combined with FBP reconstruction of a 59-year old patient shows unlayered enhanced wall thickening at the lower esophagus with histopathological T3N1M0. E: A 55-year old patient with T3N0M0; axial image obtained using GSI assist at 50 KeV shows more obvious enhanced wall thickening than the image obtained by conventional 120 kVp. F: A 61-year old patient with T3N0M0; EICT combined with GSI assist exhibits unlayered enhanced esophageal wall thickening surrounding the air-filled lumen. EICT: Esophageal insufflation computed tomography; ESCC: Esophageal squamous cell carcinoma.](WJG-24-4197-g004){#F4}

Special CT features for T3 and T4 stage differentiation
-------------------------------------------------------

The optimal monochromatic image with the best CNR in groups B and C was mainly located at (50.18 ± 2.64) KeV. The CNR~lesion-to-adipose~ at 50 keV in groups B and C was higher than that of group A (*P* \< 0.05); however, there was no significant difference in the CNR~lesion-to-adipose~ between groups B and C (*P* \< 0.05). In terms of the morphological change of the triangular area in front of the vertebral body, the proportion of adipose blur or disappearance in groups A, B and C was 40%, 30% and 22% (for the T3 stage) and 50%, 57% and 54% (for the T4 stage) for medullary ESCC, respectively; 25%, 0% and 0% (for the T3 stage) and 0% in all groups (for the T4 stage) for the ulcer type; and 0% in all groups (for the T3 and T4 stage) for the mushroom type. There were no significant differences in morphological changes between the T3 and T4 stages for medullary type, ulcerative type and mushroom type ESCC (Table [3](#T3){ref-type="table"}).

###### 

Comparisons between morphological changes of the triangular area in front of the vertebral body and pathological T stage

  **Group**                **Morphological change of triangle area in front of vertebral body**   **Medullary type**   **Ulcerative type**   **Mushroom type**   **Total**            
  ------------------------ ---------------------------------------------------------------------- -------------------- --------------------- ------------------- ----------- --- ---- ----
  A                        Clear                                                                  6                    3                     3                   0           3   0    15
  Blurred or disappeared   4                                                                      3                    1                     0                   0           0   8    
  Total                    10                                                                     6                    4                     0                   3           0   23   
  B                        Clear                                                                  7                    3                     5                   0           3   0    18
  Blurred or disappeared   3                                                                      4                    0                     0                   0           0   7    
  Total                    10                                                                     7                    5                     0                   3           0   25   
  C                        Clear                                                                  7                    6                     5                   0           2   0    20
  Blurred or disappeared   2                                                                      7                    0                     0                   0           0   9    
  Total                    9                                                                      13                   5                     0                   2           0   29   

The quantitative parameters IC and NIC of adipose tissue in the triangular area in front of the vertebral body during arterial phase (AP) and venous phase showed significant differences in their ability to discriminate the T3 and T4 stages (*P* \< 0.05). The receiver operating characteristic curve demonstrated that the area under the curve for NIC was higher than that for IC. When the threshold of NIC during AP was -0.03, the sensitivity and specificity for identifying the T3 stage were 83.30% and 83.33%, respectively (Figure [5](#F5){ref-type="fig"}).

![Receiver operating characteristic curves. Graphs showing the sensitivity and specificity of both iodine concentration and normalized iodine concentration of adipose tissue in the triangular area in front of the vertebral body during the arterial phase and the venous phase for differential diagnosis of T3 and T4 stages. AP: Arterial phase; VP: Venous phase; IC: Iodine concentration; NIC: Normalized iodine concentration.](WJG-24-4197-g005){#F5}

Combined analyses of the morphological features and NIC during AP in the triangular area in front of the vertebral body highlighted a significant difference in discriminating T3 and T4 stage medullary ESCC in groups B and C (*P* \< 0.05), and there were no significant differences between T3 and T4 stage ulcer and mushroom type ESCC (*P* \> 0.05 for all) (Table [4](#T4){ref-type="table"}, Figure [6](#F6){ref-type="fig"}).

###### 

Comparison of pathological T stage and combined diagnosis of the triangular area in front of the vertebral body

  **Group**   **T stage**   **Medullary type**   **Ulcerative type**   **Mushroom type**   **Total**            
  ----------- ------------- -------------------- --------------------- ------------------- ----------- --- ---- ----
  A           T3            6                    1                     3                   0           3   0    13
  T4          4             5                    1                     0                   0           0   10   
  Total       10            6                    4                     0                   3           0   23   
  B           T3            8                    1                     5                   0           3   0    17
  T4          2             6                    0                     0                   0           0   8    
  Total       10            7                    5                     0                   3           0   25   
  C           T3            6                    2                     5                   0           2   0    15
  T4          3             11                   0                     0                   0           0   14   
  Total       9             13                   5                     0                   2           0   29   

![Typical cases showing differences between the T3 and T4 stages of esophageal squamous cell carcinoma. A: Image from a 62-year old patient with T3N0M0 obtained using EICT combined GSI assist shows a clear triangular area in front of the vertebral body. B: IC in the triangle area during the AP was quantified to be -8.85 μg/cm^3^, and NIC during the AP was -0.05 μg/cm^3^. C: An axial image of a 57-year old patient obtained by EICT combined with GSI assist during the AP shows that the adipose tissue of the triangular area disappeared with suspected tumor invasion. D: IC in the triangle area during the AP was quantified to be -0.62 μg/cm^3^, and NIC during the AP was -0.01 μg/cm^3^. EICT: Esophageal insufflation computed tomography; IC: Iodine concentration; NIC: Normalized iodine concentration; AP: Arterial phase.](WJG-24-4197-g006){#F6}

T stage comparisons
-------------------

The sensitivity and accuracy in group C in terms of diagnosing the T1/2 stage were higher than those in the other groups. With regard to diagnosing the T3 stage, the sensitivity and specificity were higher in group C than in the other groups. The accuracy of diagnosing the T4 stage between groups was similar (Table [5](#T5){ref-type="table"}).

###### 

Accuracy of T stage comparisons between groups

  **Stage**   **Group**   ***n***   **TP**   **TN**   **FP**   **FN**   **Sensitivity (%)**   **Specificity (%)**   **Accuracy (%)**   **PPV (%)**   **NPV (%)**
  ----------- ----------- --------- -------- -------- -------- -------- --------------------- --------------------- ------------------ ------------- -------------
              A           45        7        9        15       14       31.82                 60.87                 46.67              43.75         48.28
  T1/2        B           40        5        9        10       16       33.33                 64.00                 52.50              35.71         61.54
              C           35        7        7        9        12       43.75                 63.16                 54.29              50.00         57.14
              A           45        7        9        10       19       41.17                 67.86                 57.78              43.75         65.52
  T3          B           40        8        8        10       14       44.44                 63.64                 55.00              50.00         58.33
              C           35        9        5        7        14       56.25                 73.68                 65.71              60.00         66.67
              A           45        5        12       1        27       83.33                 69.23                 71.11              29.41         96.43
  T4          B           40        6        10       1        23       85.71                 69.70                 72.50              37.50         95.83
              C           35        11       7        2        15       84.62                 68.18                 74.29              61.11         94.12

TP: True positive; TN: True negative; FP: False positive; FN: False negative; PPV: Positive predictive value; NPV: Negative predictive value.

Compared with the pathological results, mucosa enhancement was identified in 31.82% (7/22), 33.33% (5/15) and 43.75% (7/16) of cases for T1/2 stage ESCC in groups A, B and C, respectively; 68.18% (15/22), 66.67% (10/15) and 56.25% (9/16) of these cases were upstaged to T3, respectively.

There were 41.17% (7/17), 44.44% (8/18) and 56.25% (9/16) cases with T3 stage ESCC in groups A, B and C, respectively; 35.29% (6/17), 27.78% (5/18) and 25% (4/16) of these cases were upstaged to the T4 stage. Four cases were characterized by blurring of adipose tissue between tumor and adjacent structures, seven cases showed significant enhancement of the esophageal layer, three cases had an unclear boundary mass or ulcer, and 23.53% (4/17), 27.78% (5/18) and 18.75% (3/16) cases were down-staged to T1/2.

Radiation dose
--------------

There were no significant differences in CTDIvol \[(5.91 ± 2.57) mGy *vs* (3.24 ± 1.20) mGy *vs* (3.65 ± 1.77) mGy\], DLP \[(167.10 ± 99.08) mGy•cm *vs* (113.24 ± 54.46) mGy•cm *vs* (117.98 ± 32.32) mGy•cm\] and ED \[(2.52 ± 1.39) mSv *vs* (1.63 ± 0.76) mSv *vs* (1.73 ± 0.44) mSv\] among the groups (*P* \> 0.05). However, groups B and C received similar effective doses but lower iodine loads than group A \[(300 *vs* 450) mgI/kg\].

DISCUSSION
==========

Reducing the radiation dose while maintaining image quality has become a key issue in CT research\[[@B16]\]. Reasonable adjustments of the ASIR-weighted value with the appropriate reduction in the scanning conditions are the main factors for low-dose scanning\[[@B17]\]. As a type of automatic dynamic real-time radiation dose control technology, GSI appropriately changes the tube to compensate for the loss of image contrast by adjusting the field of view, rotation speed and detector width\[[@B18],[@B19]\]. Our study shows that the CNRs of groups B and C were superior to the CNR of group A. Thus, GSI assist combined with ASIR achieved equal or higher image quality than conventional scanning. Low-dose scanning brings benefits to patients with esophageal cancer\[[@B20]\]. Radiation from multiple follow-ups can be potentially harmful to patients who receive multiple radiation or chemotherapy treatments.

The esophageal wall is composed of a mucosal layer, a submucosal layer, a muscle layer and an outer membrane layer. The infiltration depth of ESCC determines the T stage. In fact, esophageal wall thickening observed on CT enhancement is largely dependent on the pathological classification. We found that T staging not only depends on the advantages of imaging techniques, but is also closely connected to the degree of esophageal lumen filling. In addition, esophageal wall shrinkage leads to incomplete lumen filling and makes it difficult to identify layers. In our study, the proportion of layered enhancement for the medullary T1/2 and T3 stages increased when we performed EICT in group C. However, no significant differences between the T1/2 and T3 stages in the ulcer and mushroom types were found. We argue that insufflation CT promotes the ability to identify lesions located on one side or around the lumen, but limitations for flat masses or local ulcers remain.

We reported that there were no significant differences between the T3 and T4 stages in all types of ESCC when only observing the morphological changes of the triangular area in front of the vertebral body. We inferred that the changes in the triangular area in medullary ESCC were affected by the size of the adipose tissue and connections with adjacent structures. Less adipose tissue and a close correlation with the triangular area are sometimes observed as blurring. Combined analysis of subjective observations and quantitative measurements revealed significant differences that could be used to discriminate T3 and T4 stage medullary ESCC in groups B and C. Hence, the better performance of the combined analysis in the triangular area was mainly attributed to the ability of NIC to discern invasion during the AP.

Based on the above analysis, the ability to diagnose T1-T3 stages is consistent with previous research\[[@B9],[@B13]\]. The accuracy and sensitivity in distinguishing the T4 stage were similar to those reported by Cerfolio et al\[[@B13]\] and Konieczny et al\[[@B10]\], while the specificity was significantly higher than that reported by Konieczny et al\[[@B10]\]. Our study included more T4 stage patients than that of Konieczny et al\[[@B10]\], and, thus, our results may be more reliable than previous reports. Therefore, our findings demonstrate the relatively stable ability of our proposed technique to discriminate peripheral invasion, such as invasion of the trachea, aorta, muscle and pericardium.

There are several limitations of our study. First, the small sample size of T4 stage patients likely impacted the comparison of the diagnostic value in this preliminary study. Second, incomplete lumen filling associated with uncertain lesions restricts tumor localization. Third, nose or mouth leaks were unavoidable when patients held their breath for a long period of time. Fourth, there is still a certain false-positive rate when analyzing the triangular area in front of the vertebral body. Furthermore, the EICT process is influenced by the patient's age and tolerance coordination. Lastly, other modalities, especially functional MRI, perform better in displaying the esophagus layer and distant metastases. Comparisons of EICT with EUS, MRI and PET-CT will be performed in the future. As mentioned above, fewer adipose tissue and close adjacent structural connections are easily misdiagnosed. The future direction of our research will focus on local expansion by lumen filling.

In conclusion, GSI optimizes the image contrast, maintains the radiation dose and reduces the contrast medium injection dose. EICT combined with GSI assist promotes differential diagnosis between T1/2 and T3 stage ESCC. The ability to differentially diagnose the T3 and T4 stages in medullary ESCC can be improved by quantitatively and qualitatively analyzing adipose tissue in front of the vertebral body.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

Conventional computed tomography (CT) has limitations for esophageal cancer staging or restaging after treatment. Diagnoses of the T1 and T2 stages exhibit low accuracy due to difficulty visualizing the esophageal mucosa. The optimal monochromatic energy level clearly displays esophageal lesions and the surrounding adipose infiltration by effectively improving the image quality and resolution.

Research motivation
-------------------

Radiation from multiple follow-ups can be potentially harmful to patients who receive multiple radiation or chemotherapy treatments. Low-dose scanning brings benefits to patients with esophageal cancer. GSI combined with ASIR achieved image quality equal to or greater than that of conventional scanning.

Research objectives
-------------------

We aimed to evaluate the T stage of esophageal cancer using low-dose spectral insufflation CT, and we discuss the accuracy of this technique for preoperatively diagnosing the T stage.

Research methods
----------------

One hundred and twenty patients with esophageal cancer were divided into three groups that included 45 patients (group A underwent conventional 120 kVp CT with 450 mgI/kg contrast medium injection), 40 patients (group B underwent GSI assist and 300 mgI/kg contrast medium injection) and 35 patients (group C underwent insufflation CT combined GSI assist and 300 mgI/kg contrast medium injection). Specific imaging features were observed, and the contrast-to-noise ratio of lesion-to-mediastinal adipose tissue was calculated for qualitative and quantitative T stage evaluation. The radiation dose was measured in each group.

Research results
----------------

When performed with insufflation CT combined with GSI assist technology, the ability to present layered enhancement was significantly different for the identification of T1/2 and T3 stage medullary esophageal cancer. Combined analyses of the morphological features and normalized iodine concentration during the arterial phase in the triangular area in front of the vertebral body highlighted a significant difference in discriminating T3 and T4 stage medullary esophageal cancer.

Research conclusions
--------------------

EUS can be clinically used to determine the infiltration of esophageal cancer and the possibility of surgical resection. However, the detection range is limited to centimeters from the center of the ultrasonic probe without interference or severe stenosis. Currently, CT and PET/CT are common methods used to evaluate the T stage before esophageal cancer treatment. Hence, we aimed to evaluate the T stage of esophageal squamous cell carcinoma using low-dose spectral insufflation CT, and we discuss the accuracy of this technique for preoperatively diagnosing the T stage. We propose the new idea that the T stage for esophageal cancer can be assessed quantitatively and qualitatively methods using low-dose spectral CT scanning. We found that insufflation CT combined GSI assist technology allows a differential diagnosis between the T1/2 and T3 stages. The ability to differentially diagnose the T3 and T4 stages in medullary esophageal cancer can be improved by analyzing the adipose tissue in front of the vertebral body.

Research perspectives
---------------------

Nose or mouth leaks are unavoidable when patients hold their breath for a long period of time. Furthermore, the process of insufflation CT is influenced by the patient's age and ability to tolerate the procedures. The future direction of our research will focus on local expansion by lumen filling.
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